TransMedics Group unveiled its Controlled Hypothermic Organ Preservation System, or CHOPS, a new active cooling device for donor organ storage. The company outlined plans for CHOPS to serve as the control arm in the ENHANCE Heart Part B and DENOVO Lung clinical trials. These updates add a new organ preservation platform alongside TransMedics Group's existing transplant technology programs. TransMedics Group (NasdaqGM:TMDX) is drawing attention with CHOPS at a time when its share price...
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
531last 24h
2513last 7d
483● bullish (7d)
258● bearish (7d)
197publishers
Simply Wall St.100d agoneutral
TransMedics Unveils CHOPS As Trials Progress And Valuation Screens Undervalued